CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study
Title:
CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study
Author:
COOPER, C.L. DAVIS, H.L. MORRIS, M.L. EFLER, S.M. ADHAMI, M. AL KRIEG, A.M. CAMERON, D.W. HEATHCOTE, J.
Appeared in:
Journal of clinical immunology
Paging:
Volume 24 (2004) nr. 6 pages 693-701
Year:
2004
Contents:
Publisher:
Kluwer Academic Publishers-Plenum Publishers, New York